WellGen, Inc.
WellGen, Inc. is a biotechnology company at the crossroads of foods and pharmaceuticals. WellGen’s mission is to discover, develop, and commercialise medical foods for inflammation-based diseases using natural products that are safe and clinically proven. Using the science of nutrigenomics, the company has developed Alignomx™, a proprietary bioinformatics model that uses gene expression data to determine optimal therapeutic areas for WellGen’s pipeline of proprietary natural products. Through its in-house expertise in nutrigenomics and natural product chemistry, WellGen is developing proprietary medical foods and has additionally identified several opportunities in the functional food and beverage and dietary supplement markets.
Medical food is an emerging high growth market estimated at over US $3 billion in global sales.
Dr. Roddy Carter, President and CEO of WellGen, said,
“Despite excellent medical care, there are a large number of major inflammation-related conditions that still challenge us with residual pathology. For WellGen, medical foods will enable us to provide natural product solutions to many of the healthcare challenges faced today.”
Amphion’s fully-diluted ownership stake in WellGen was 14.94% at 31 December 2009, valued at US $6.7 million (2008: US $6.7 million).
Management
Dr. Roddy Carter - President and Chief Executive Officer
Robert M. Hellauer - Chief Financial Officer
Dr. Nancy E. Rawson - Chief Scientific Officer
Patricia Lucas-Schnarre - Vice President, Product Development and Marketing
Catherine Segal, R.Ph. - Vice President, Business Development
Board of Directors
Richard C.E. Morgan - (Chairman) Chief Executive Officer, Amphion Innovations
Richard Laster - (Vice Chairman) Management Consultant, former Chief Executive Officer, DNA Plant Technology Corp., EVP, General Foods, President, Maxwell House Coffee
Robert J. Bertoldi - President and Chief Financial Officer, Amphion Innovations
Irwin Engelman - Former Chief Financial Officer, General Foods Corp.
Scott Korman - President, Nashone Inc.
Dr. Laura Philips - Former Chief Operating Officer, NexGenix Pharmaceuticals; former Executive, Corning, Inc. Dr. William R. Sharp Partner, GNP LLC
